Long-term Observational Study to Evaluate the DFS and OS of Adjuvant FOLFIRINOX Regimen in Pancreatic Cancer Patients

Randomized Phase II Study of FOLFOX Versus FOLFIRI.3 in Gemcitabine-refractory Pancreatic Cancer

NCT00786006 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Tolerance Evaluation in FOLFIRINOX Dose Adjusted in Elderly Patients With a Metastatic Pancreatic Cancer

NCT02143219 ·Status: COMPLETED ·Phase: PHASE2

Modified FOLFIRINOX for Gemcitabine Refractory Pancreatic Cancer: A Phase II Multicenter Trial

NCT02440958 ·Status: COMPLETED ·Phase: PHASE2

Study of Modified FOLFIRINOX in Advanced Pancreatic Cancer

NCT01523457 ·Status: COMPLETED ·Phase: PHASE2

Comparison FOLFIRINOX Panitumumab vs mFOLFOX6 Panitumumab in RAS/B-RAF Wild-type Metastatic Colorectal Cancer Patients

NCT02980510 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

NCT01413022 ·Status: COMPLETED ·Phase: PHASE1

FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma

NCT01383538 ·Status: COMPLETED ·Phase: PHASE1

A Study of Administering FOLFIRINOX Before Surgery For Potentially Curable Pancreatic Cancer

NCT03167112 ·Status: UNKNOWN ·Phase: PHASE2

FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer

NCT04141995 ·Status: TERMINATED ·Phase: PHASE2

A Study of Perioperative Chemotherapy Plus Panitumumab in Patients With Colorectal Cancer Liver Metastases

NCT01260415 ·Status: COMPLETED ·Phase: PHASE2

Ph 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular Carcinoma

NCT02102022 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

mFOLFOX vs. mFOLFIRI in Advanced or Recurrent Biliary Tract Cancer Refractory to First Line

NCT03464968 ·Status: COMPLETED ·Phase: PHASE2

mFOLFOX/mFOLFIRI vs. mFOLFOX in Advanced or Recurrent Biliary Tract Cancer Second-line

NCT07062536 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Induction Chemotherapy, FOLFIRINOX Followed With Concurrent Capecitabine and Radiation Therapy in Inoperable Locally Advanced Cancer of the Pancreas

NCT02311439 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Second Line Chemotherapy for Advanced Pancreatic Cancer

NCT01543412 ·Status: COMPLETED ·Phase: PHASE2

Chemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown Primary

NCT04325425 ·Status: RECRUITING ·Phase: PHASE2

FOLFIRI or mFOLFOX6 in Adjuvant Chemotherapy in Advanced Colorectal Cancer

NCT01566942 ·Status: UNKNOWN ·Phase: PHASE3

Investigate the Efficacy of Chemotherapy in Patients With Positive ctDNA After Surgery and Adjuvant Chemotherapy for a Stage III Colorectal Cancer

NCT06197425 ·Status: RECRUITING ·Phase: PHASE3

Study to Evaluate the Efficacy and Safety of FOLFIRI-AD in Patients With Metastatic Colorectal Cancer UGT1A Genotype 1

NCT01639326 ·Status: UNKNOWN ·Phase: PHASE2

Study to Evaluate the Efficacy of FOLFOX + Panitumumab Followed by FOLFIRI + Bevacizumab (Sequence 1) Versus FOLFOX + Bevacizumab Followed by FOLFIRI + Panitumumab (Sequence 2) in Untreated Patients With Wild-type RAS Metastatic, Primary Left-sided, Unresectable Colorectal Cancer

NCT03635021 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Trial Comparing Two Two Sequences of Therapy in Colorectal Metastatic Patients

NCT01030042 ·Status: COMPLETED ·Phase: PHASE3

Adjuvant mFOLFIRINOX for High-risk Stage III Colon Cancer

NCT05179889 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies

NCT01643499 ·Status: COMPLETED ·Phase: PHASE1

FOLFIRINOX in Patients With Inoperable Pancreatic Cancer

NCT01359007 ·Status: TERMINATED ·Phase: PHASE2

Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

NCT00006115 ·Status: UNKNOWN ·Phase: PHASE2